Global Trade Disruptions: The Impact of Tariff Policies on Ayurvedic Pharmaceutical Companies and the Herbal Medicine Trade

The global herbal medicine industry, anchored by traditional systems such as Ayurveda, faces emerging challenges due to shifting international trade policies and tariff impositions. This article examines the potential impact of tariffs—particularly those proposed by major importers like the United States—on the export dynamics of Ayurvedic pharmaceutical companies and herbal formulations. While herbal drugs are currently exempt from punitive tariffs, ongoing investigations and policy shifts pose risks to market access, price competitiveness, and regulatory compliance. The analysis highlights the vulnerability of small and medium enterprises (SMEs), the strategic responses adopted by leading Ayurvedic firms, and the broader economic implications for India’s integrative healthcare sector. Recommendations include market diversification, digital expansion, and policy advocacy to safeguard the global momentum of herbal medicine. The article underscores the need for a balanced trade framework that respects the therapeutic and cultural significance of traditional medical systems.